ZA928159B - N-Phenyl-2-cyano-3-hydroxycrotonamide derivatives and their use as pharmaceuticals having an immunomodulatory property. - Google Patents
N-Phenyl-2-cyano-3-hydroxycrotonamide derivatives and their use as pharmaceuticals having an immunomodulatory property.Info
- Publication number
- ZA928159B ZA928159B ZA928159A ZA928159A ZA928159B ZA 928159 B ZA928159 B ZA 928159B ZA 928159 A ZA928159 A ZA 928159A ZA 928159 A ZA928159 A ZA 928159A ZA 928159 B ZA928159 B ZA 928159B
- Authority
- ZA
- South Africa
- Prior art keywords
- cyano
- phenyl
- pharmaceuticals
- alkyl
- hydroxycrotonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C255/27—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups, amino groups and doubly-bound oxygen atoms bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4134934 | 1991-10-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA928159B true ZA928159B (en) | 1993-08-04 |
Family
ID=6443223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA928159A ZA928159B (en) | 1991-10-23 | 1992-10-22 | N-Phenyl-2-cyano-3-hydroxycrotonamide derivatives and their use as pharmaceuticals having an immunomodulatory property. |
Country Status (23)
Country | Link |
---|---|
US (2) | US5747664A (xx) |
EP (1) | EP0538783B1 (xx) |
JP (1) | JP3119738B2 (xx) |
KR (1) | KR930007443A (xx) |
CN (1) | CN1071833A (xx) |
AT (1) | ATE128353T1 (xx) |
AU (1) | AU658679B2 (xx) |
BR (1) | BR9204124A (xx) |
CA (1) | CA2081173A1 (xx) |
CZ (1) | CZ281693B6 (xx) |
DE (1) | DE59203828D1 (xx) |
DK (1) | DK0538783T3 (xx) |
ES (1) | ES2079765T3 (xx) |
FI (1) | FI924779A (xx) |
GR (1) | GR3017751T3 (xx) |
HU (1) | HUT63610A (xx) |
IL (1) | IL103487A (xx) |
MX (1) | MX9206082A (xx) |
NO (1) | NO178922C (xx) |
NZ (1) | NZ244814A (xx) |
RU (1) | RU2090553C1 (xx) |
SK (1) | SK319892A3 (xx) |
ZA (1) | ZA928159B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6133301A (en) * | 1991-08-22 | 2000-10-17 | Aventis Pharma Deutschland Gmbh | Pharmaceuticals for the treatment of rejection reactions in organ transplantations |
DE4127737A1 (de) | 1991-08-22 | 1993-02-25 | Hoechst Ag | Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen |
WO1994024095A1 (en) * | 1993-04-16 | 1994-10-27 | Abbott Laboratories | Immunosuppressive agents |
US5519042A (en) * | 1994-01-13 | 1996-05-21 | Hoechst Aktiengesellschaft | Method of treating hyperproliferative vascular disease |
US5624946A (en) * | 1994-07-05 | 1997-04-29 | Williams; James | Use of leflunomide to control and reverse chronic allograft rejection |
DE19539638A1 (de) * | 1995-10-25 | 1997-04-30 | Hoechst Ag | Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen |
DE19547648A1 (de) * | 1995-12-20 | 1997-06-26 | Hoechst Ag | Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate |
US6011051A (en) * | 1996-07-31 | 2000-01-04 | Hoechst Aktiengesellschaft | Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
DE19702988A1 (de) * | 1997-01-28 | 1998-07-30 | Hoechst Ag | Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika |
US6303652B1 (en) | 1998-08-21 | 2001-10-16 | Hughes Institute | BTK inhibitors and methods for their identification and use |
US6355678B1 (en) * | 1998-06-29 | 2002-03-12 | Parker Hughes Institute | Inhibitors of the EGF-receptor tyrosine kinase and methods for their use |
DE19857009A1 (de) * | 1998-12-10 | 2000-06-15 | Aventis Pharma Gmbh | Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren |
DE102005017592A1 (de) * | 2005-04-16 | 2006-10-19 | Lindner, Jürgen, Dr. med. | Darreichungsformen und Kombinationspräparate von Pyrimidinbiosyntheseinhibitoren zur Erzielung zusätzlicher Wirkungen auf das Immunsystem |
US20160287549A1 (en) | 2013-11-22 | 2016-10-06 | Genzyme Corporation | Novel methods for treating neurodegenerative diseases |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL186239B (nl) * | 1975-06-05 | Hoechst Ag | Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze. | |
DE2555789A1 (de) * | 1975-12-11 | 1977-07-07 | Hoechst Ag | Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel |
JPH0776202B2 (ja) * | 1985-07-01 | 1995-08-16 | 三井東圧化学株式会社 | アシルアミノブテニルニトリル誘導体、その製造法およびそれらを含有する除草剤および農園芸用殺菌剤 |
DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
GB8619432D0 (en) * | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
DE69002792T2 (de) * | 1989-05-09 | 1993-12-09 | Sds Biotech Corp | Crotonsäureamidderivate und sie enthaltende Insektizide. |
DD297328A5 (de) * | 1989-08-18 | 1992-01-09 | �������@���������k���Kk�� | 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen |
US5034410A (en) * | 1989-10-11 | 1991-07-23 | Syntex (U.S.A.) Inc. | Anthelmintically active benzenepropanamide derivatives |
IL99811A (en) * | 1990-10-30 | 1996-03-31 | Roussel Uclaf | 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them |
-
1992
- 1992-10-20 DK DK92117906.5T patent/DK0538783T3/da active
- 1992-10-20 EP EP92117906A patent/EP0538783B1/de not_active Expired - Lifetime
- 1992-10-20 ES ES92117906T patent/ES2079765T3/es not_active Expired - Lifetime
- 1992-10-20 DE DE59203828T patent/DE59203828D1/de not_active Expired - Lifetime
- 1992-10-20 NZ NZ244814A patent/NZ244814A/en unknown
- 1992-10-20 AT AT92117906T patent/ATE128353T1/de not_active IP Right Cessation
- 1992-10-21 FI FI924779A patent/FI924779A/fi not_active Application Discontinuation
- 1992-10-21 IL IL103487A patent/IL103487A/en not_active IP Right Cessation
- 1992-10-22 HU HU9203327A patent/HUT63610A/hu unknown
- 1992-10-22 AU AU27215/92A patent/AU658679B2/en not_active Ceased
- 1992-10-22 ZA ZA928159A patent/ZA928159B/xx unknown
- 1992-10-22 BR BR929204124A patent/BR9204124A/pt not_active Application Discontinuation
- 1992-10-22 CA CA002081173A patent/CA2081173A1/en not_active Abandoned
- 1992-10-22 MX MX9206082A patent/MX9206082A/es not_active IP Right Cessation
- 1992-10-22 SK SK3198-92A patent/SK319892A3/sk unknown
- 1992-10-22 KR KR1019920019409A patent/KR930007443A/ko not_active Application Discontinuation
- 1992-10-22 RU RU9292004357A patent/RU2090553C1/ru active
- 1992-10-22 JP JP04284294A patent/JP3119738B2/ja not_active Expired - Lifetime
- 1992-10-22 NO NO924093A patent/NO178922C/no not_active IP Right Cessation
- 1992-10-22 CZ CS923198A patent/CZ281693B6/cs not_active IP Right Cessation
- 1992-10-23 CN CN92112459A patent/CN1071833A/zh active Pending
-
1994
- 1994-12-07 US US08/350,740 patent/US5747664A/en not_active Expired - Lifetime
-
1995
- 1995-10-16 GR GR950402851T patent/GR3017751T3/el unknown
-
1997
- 1997-07-29 US US08/902,626 patent/US5773470A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IL103487A (en) | 1998-01-04 |
CA2081173A1 (en) | 1993-04-24 |
DK0538783T3 (da) | 1996-02-05 |
NZ244814A (en) | 1994-06-27 |
CZ319892A3 (en) | 1993-05-12 |
JP3119738B2 (ja) | 2000-12-25 |
CZ281693B6 (cs) | 1996-12-11 |
IL103487A0 (en) | 1993-03-15 |
US5773470A (en) | 1998-06-30 |
BR9204124A (pt) | 1993-06-01 |
MX9206082A (es) | 1993-07-01 |
EP0538783A1 (de) | 1993-04-28 |
HU9203327D0 (en) | 1992-12-28 |
AU658679B2 (en) | 1995-04-27 |
EP0538783B1 (de) | 1995-09-27 |
FI924779A (fi) | 1993-04-24 |
NO178922B (no) | 1996-03-25 |
KR930007443A (ko) | 1993-05-20 |
US5747664A (en) | 1998-05-05 |
JPH05201948A (ja) | 1993-08-10 |
GR3017751T3 (en) | 1996-01-31 |
HUT63610A (en) | 1993-09-28 |
NO924093L (no) | 1993-04-26 |
FI924779A0 (fi) | 1992-10-21 |
ES2079765T3 (es) | 1996-01-16 |
ATE128353T1 (de) | 1995-10-15 |
RU2090553C1 (ru) | 1997-09-20 |
CN1071833A (zh) | 1993-05-12 |
NO178922C (no) | 1996-07-03 |
NO924093D0 (no) | 1992-10-22 |
DE59203828D1 (de) | 1995-11-02 |
AU2721592A (en) | 1993-04-29 |
SK319892A3 (en) | 1995-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL103487A0 (en) | N-phenyl-2-cyano-3-hydroxycrotonamide derivatives and their use as pharmaceuticals having an immunomodulatory property | |
FI912998A (fi) | Foerfarande foer framstaellning av aralifatiskt n-substituerade aminoalkanfosfinsyror. | |
ZA918126B (en) | Di(aromatic)compounds and their use in human and veterinary medicine and in cosmetics | |
PH25571A (en) | Alpha'-alkyl-4-amino-3-quinolinemethanols, 1-(4-aralkylamino-3-quinolinyl) alaknones, their use as medicaments | |
ATE8050T1 (de) | N-(4-aminobenzoyl)-n'-benzylbispidin, seine herstellung und dieses enthaltende arzneimittel. | |
DE59200773D1 (de) | Arzneimittel zur Behandlung von Abstossungsreaktionen bei Organverpflanzungen. | |
DE69024778D1 (de) | 2-Aminopyrimidin-4-carboxamid-Derivate, deren Herstellung und deren therapeutische Anwendung | |
DK0572635T3 (da) | Hidtil ukendte forbindelser med guanidinstruktur og farmaceutisk komposition indeholdende forbindelserne | |
ATE173252T1 (de) | Arylmorpholine, herstellung und verwendung | |
EP0481299A3 (en) | N-phenyl-piperidyl-4-amines and drugs containing them | |
IL107454A0 (en) | Pharmaceutical compositions containing imidazol-1-yl compounds | |
ATE131819T1 (de) | 2-hydroxy-3-phenoxy-propyl-substituierte piperazine, ihre herstellung und verwendung | |
DK0628039T3 (da) | 2,3,4,5-tetrahydro-1H-benzazepiner og farmaceutisk acceptable syreadditionssalte deraf. | |
PT78155B (de) | N-(3-trifluormethylphenyl)-n'-propargylpiperazin seine herstellung und verwendung | |
ATE63309T1 (de) | 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel. |